Australian Super Pty LTD Bristol Myers Squibb CO Transaction History

Australian Super Pty LTD

  • $17.1 Billion
  • Q2 2024

A detailed history of Australian Super Pty LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Australian Super Pty LTD holds 3,857,561 shares of BMY stock, worth $188 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
3,857,561
Previous 3,081,653 25.18%
Holding current value
$188 Million
Previous $167 Million 4.14%
% of portfolio
0.94%
Previous 0.99%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024
BUY
$40.25 - $52.99 $31.2 Million - $41.1 Million
775,908 Added 25.18%
3,857,561 $160 Million
Q1 2024

Apr 26, 2024
BUY
$47.98 - $54.4 $66.5 Million - $75.4 Million
1,386,762 Added 81.82%
3,081,653 $167 Million
Q4 2023

Jan 16, 2024
BUY
$48.48 - $57.85 $82.2 Million - $98 Million
1,694,891 New
1,694,891 $87 Million
Q2 2023

Jul 28, 2023
SELL
$63.71 - $70.74 $815,042 - $904,976
-12,793 Reduced 33.47%
25,432 $1.63 Million
Q1 2023

Apr 21, 2023
SELL
$65.71 - $74.53 $75.8 Million - $85.9 Million
-1,153,158 Reduced 96.79%
38,225 $2.65 Million
Q4 2022

Feb 01, 2023
BUY
$68.48 - $81.09 $2.05 Million - $2.43 Million
29,965 Added 2.58%
1,191,383 $85.7 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $51,730 - $30.6 Million
-397,929 Reduced 25.52%
1,161,418 $82.6 Million
Q2 2022

Jul 13, 2022
BUY
$72.62 - $79.98 $5.16 Million - $5.68 Million
71,054 Added 4.77%
1,559,347 $120 Million
Q1 2022

Apr 29, 2022
SELL
$61.48 - $73.72 $20.8 Million - $25 Million
-338,678 Reduced 18.54%
1,488,293 $109 Million
Q4 2021

Jan 24, 2022
BUY
$53.63 - $62.52 $38.1 Million - $44.4 Million
710,844 Added 63.69%
1,826,971 $114 Million
Q3 2021

Nov 12, 2021
BUY
$59.17 - $69.31 $11.3 Million - $13.2 Million
190,988 Added 20.64%
1,116,127 $66 Million
Q2 2021

Aug 12, 2021
BUY
$61.91 - $67.42 $9.2 Million - $10 Million
148,594 Added 19.14%
925,139 $61.8 Million
Q1 2021

May 14, 2021
SELL
$59.34 - $66.74 $116 Million - $131 Million
-1,960,945 Reduced 71.63%
776,545 $49 Million
Q4 2020

Feb 11, 2021
BUY
$57.74 - $65.43 $15.8 Million - $17.9 Million
274,189 Added 11.13%
2,737,490 $170 Million
Q3 2020

Nov 16, 2020
BUY
$57.43 - $63.64 $75.9 Million - $84.1 Million
1,321,614 Added 115.76%
2,463,301 $149 Million
Q2 2020

Aug 13, 2020
BUY
$54.82 - $64.09 $28.9 Million - $33.8 Million
527,200 Added 85.8%
1,141,687 $67.1 Million
Q1 2020

May 13, 2020
BUY
$46.4 - $67.43 $14.1 Million - $20.5 Million
304,086 Added 97.97%
614,487 $34.3 Million
Q4 2019

Feb 10, 2020
BUY
$49.21 - $64.19 $6.43 Million - $8.38 Million
130,586 Added 72.62%
310,401 $19.9 Million
Q3 2019

Nov 08, 2019
BUY
$42.77 - $50.71 $7.69 Million - $9.12 Million
179,815 New
179,815 $9.12 Million

Others Institutions Holding BMY

# of Institutions
2,399
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $104B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Australian Super Pty LTD Portfolio

Follow Australian Super Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Australian Super Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Australian Super Pty LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email